Clinical Trial Update: An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease

View source ↗

Summary

An observational clinical trial evaluating subcutaneous infusion of ABBV-951 in adult Japanese participants with advanced Parkinson's disease to assess changes …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ABBV-951

Snippet

Sponsor: AbbVie | Conditions: Parkinson's Disease (PD) | Status: RECRUITING